<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 08:32:40 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Rochon family buys $100M in AIAI Holdings shares at $20 each</title>
   <link>http://www.streetinsider.com/Insider+Trades/Rochon+family+buys+%24100M+in+AIAI+Holdings+shares+at+%2420+each/26663356.html</link>
   <description>&lt;p&gt;John P. Rochon, chairman of AIAI Holdings Corporation (NASDAQ: AIAI), and entities controlled by his family have acquired approximately $100 million worth of company shares at $20.00 per share through a privately negotiated transaction with an existing large shareholder, according to a press release from the company.&lt;/p&gt;&lt;p&gt;The transaction increases the Rochon family's existing ownership position in the Dallas-based company. AIAI Holdings said it was not involved in negotiating the deal and will not receive any proceeds from the transaction.&lt;/p&gt;&lt;p&gt;&quot;This is not simply a financial investment; it is a statement of belief in where Ai² is going and how we intend</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Insider+Trades/Rochon+family+buys+%24100M+in+AIAI+Holdings+shares+at+%2420+each/26663356.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:32:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>Rochon family buys $100M in AIAI Holdings shares at $20 each</title>
   <link>http://www.streetinsider.com/Corporate+News/Rochon+family+buys+%24100M+in+AIAI+Holdings+shares+at+%2420+each/26663356.html</link>
   <description>&lt;p&gt;John P. Rochon, chairman of AIAI Holdings Corporation (NASDAQ: AIAI), and entities controlled by his family have acquired approximately $100 million worth of company shares at $20.00 per share through a privately negotiated transaction with an existing large shareholder, according to a press release from the company.&lt;/p&gt;&lt;p&gt;The transaction increases the Rochon family's existing ownership position in the Dallas-based company. AIAI Holdings said it was not involved in negotiating the deal and will not receive any proceeds from the transaction.&lt;/p&gt;&lt;p&gt;&quot;This is not simply a financial investment; it is a statement of belief in where Ai² is going and how we intend</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Rochon+family+buys+%24100M+in+AIAI+Holdings+shares+at+%2420+each/26663356.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:32:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>Rochon Family Executes Strategic Purchase of AIAI Holdings Shares</title>
   <link>http://www.streetinsider.com/Press+Releases/Rochon+Family+Executes+Strategic+Purchase+of+AIAI+Holdings+Shares/26663324.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;DALLAS, TX / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 18, 2026 / &lt;/strong&gt;&lt;strong&gt;AIAI Holdings Corporation (NASDAQ:AIAI) (&quot;Ai²&quot; or the &quot;Company&quot;)&lt;/strong&gt;, an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that John P. Rochon, Chairman of Ai² and entities controlled by the family of Mr. Rochon, collectively, have acquired approximately $100 million of Ai² shares at $20.00 per share through a privately negotiated transaction with an existing large shareholder.&lt;/p&gt;&lt;p&gt;This transaction represents a significant incremental investment by the Rochon family, further increasing their already substantial ownership position in Ai². The purchase</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Rochon+Family+Executes+Strategic+Purchase+of+AIAI+Holdings+Shares/26663324.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>Rochon Family Executes Strategic Purchase of AIAI Holdings Shares</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/Rochon+Family+Executes+Strategic+Purchase+of+AIAI+Holdings+Shares/26663324.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;DALLAS, TX / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 18, 2026 / &lt;/strong&gt;&lt;strong&gt;AIAI Holdings Corporation (NASDAQ:AIAI) (&quot;Ai²&quot; or the &quot;Company&quot;)&lt;/strong&gt;, an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that John P. Rochon, Chairman of Ai² and entities controlled by the family of Mr. Rochon, collectively, have acquired approximately $100 million of Ai² shares at $20.00 per share through a privately negotiated transaction with an existing large shareholder.&lt;/p&gt;&lt;p&gt;This transaction represents a significant incremental investment by the Rochon family, further increasing their already substantial ownership position in Ai². The purchase</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/Rochon+Family+Executes+Strategic+Purchase+of+AIAI+Holdings+Shares/26663324.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, June  09, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) &lt;/strong&gt;a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Interested parties can access the live presentation through the following link: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=oZxnyyxmH4mzOiXakKWeioP9mUjoKDxIngIbjjKxQGLBK-IXi3iRIaJI_KJcWJWr29R0M2VhGmp_RZo_tDBlcUXYq1cw87Urn2l_1rjYR2HRXTf1CKnNuDvUemxuUat3v1sDTnG-wXjQSvQfP1OeEI4ZqbYQtnA2u7tQenn0P1k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Access Live Presentation&lt;/a&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Company will also participate in one-on-one meetings at the virtual</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Announces+Presentation+at+Sidoti+Small+Cap+Conference+on+June+18%2C+2026/26620048.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>AIAI Holdings launches Arca Wallet for digital dollar management</title>
   <link>http://www.streetinsider.com/Corporate+News/AIAI+Holdings+launches+Arca+Wallet+for+digital+dollar+management/26588193.html</link>
   <description>&lt;p&gt;AIAI Holdings Corporation (NASDAQ: AIAI) and its subsidiary Constellation Network announced the launch of Arca Wallet, a self-custodial mobile application for managing digital dollars. The wallet is available for download on the App Store and Google Play.&lt;/p&gt;&lt;p&gt;Arca Wallet allows users to hold, send, and manage digital dollars directly from smartphones without requiring a bank account. The application supports USDC and USDT, U.S. dollar-denominated digital currencies that are redeemable 1:1 for U.S. dollars by regulated third parties.&lt;/p&gt;&lt;p&gt;The wallet operates on a self-custodial model, meaning users maintain exclusive control over their digital assets. Setup takes approximately 30 seconds through email or social</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/AIAI+Holdings+launches+Arca+Wallet+for+digital+dollar+management/26588193.html</guid>
   <pubDate>Tue, 02 Jun 2026 08:32:35 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>AIAI Holdings and Constellation Network Launch Arca Wallet, a Wallet to Self-Manage Digital Dollars</title>
   <link>http://www.streetinsider.com/Press+Releases/AIAI+Holdings+and+Constellation+Network+Launch+Arca+Wallet%2C+a+Wallet+to+Self-Manage+Digital+Dollars/26588154.html</link>
   <description>
      &lt;p&gt;&lt;i&gt;&lt;strong&gt;New Mobile Wallet Combines Digital Dollar Management, Streamlined Identity Verification and an Integrated App Marketplace Designed to Expand Access to Global Payments&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;DALLAS, TX / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 2, 2026 / &lt;/strong&gt;&lt;strong&gt;AIAI Holdings Corporation (NASDAQ:AIAI) (&quot;Ai&lt;sup&gt;2&lt;/sup&gt;&quot; or the &quot;Company&quot;)&lt;/strong&gt;, an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, along with its subsidiary portfolio company Constellation Network, a blockchain and data infrastructure company, today announced the public launch of Arca Wallet, a self-custodial mobile dollar wallet that enables anyone, anywhere, to hold, send, and manage digital dollars directly from</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AIAI+Holdings+and+Constellation+Network+Launch+Arca+Wallet%2C+a+Wallet+to+Self-Manage+Digital+Dollars/26588154.html</guid>
   <pubDate>Tue, 02 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>AIAI Holdings and Constellation Network Launch Arca Wallet, a Wallet to Self-Manage Digital Dollars</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/AIAI+Holdings+and+Constellation+Network+Launch+Arca+Wallet%2C+a+Wallet+to+Self-Manage+Digital+Dollars/26588154.html</link>
   <description>
      &lt;p&gt;&lt;i&gt;&lt;strong&gt;New Mobile Wallet Combines Digital Dollar Management, Streamlined Identity Verification and an Integrated App Marketplace Designed to Expand Access to Global Payments&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;DALLAS, TX / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 2, 2026 / &lt;/strong&gt;&lt;strong&gt;AIAI Holdings Corporation (NASDAQ:AIAI) (&quot;Ai&lt;sup&gt;2&lt;/sup&gt;&quot; or the &quot;Company&quot;)&lt;/strong&gt;, an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, along with its subsidiary portfolio company Constellation Network, a blockchain and data infrastructure company, today announced the public launch of Arca Wallet, a self-custodial mobile dollar wallet that enables anyone, anywhere, to hold, send, and manage digital dollars directly from</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/AIAI+Holdings+and+Constellation+Network+Launch+Arca+Wallet%2C+a+Wallet+to+Self-Manage+Digital+Dollars/26588154.html</guid>
   <pubDate>Tue, 02 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>AIAI Holdings' Constellation Network Unveils Gate AI Security Gateway and Performance Benchmarks Ahead of June Launch</title>
   <link>http://www.streetinsider.com/Press+Releases/AIAI+Holdings%27+Constellation+Network+Unveils+Gate+AI+Security+Gateway+and+Performance+Benchmarks+Ahead+of+June+Launch/26561657.html</link>
   <description>
      &lt;p&gt;&lt;i&gt;&lt;strong&gt;Technical report identifies Gate AI as one of the top performing AI security gateways across 16 public prompt injection evaluations, ranking first on half of the evaluated datasets.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;DALLAS, TX / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / May 28, 2026 / &lt;/strong&gt;&lt;strong&gt;AIAI Holdings Corporation (NASDAQ:AIAI) (&quot;Ai&lt;sup&gt;2&lt;/sup&gt;&quot; or the &quot;Company&quot;)&lt;/strong&gt;, an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that one of its portfolio companies, Constellation Network, its blockchain and data infrastructure company, will launch its AI security gateway product, Constellation Gate AI, in June 2026. Ahead of the launch, Constellation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AIAI+Holdings%27+Constellation+Network+Unveils+Gate+AI+Security+Gateway+and+Performance+Benchmarks+Ahead+of+June+Launch/26561657.html</guid>
   <pubDate>Thu, 28 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>AIAI Holdings' Constellation Network Unveils Gate AI Security Gateway and Performance Benchmarks Ahead of June Launch</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/AIAI+Holdings%27+Constellation+Network+Unveils+Gate+AI+Security+Gateway+and+Performance+Benchmarks+Ahead+of+June+Launch/26561657.html</link>
   <description>
      &lt;p&gt;&lt;i&gt;&lt;strong&gt;Technical report identifies Gate AI as one of the top performing AI security gateways across 16 public prompt injection evaluations, ranking first on half of the evaluated datasets.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;DALLAS, TX / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / May 28, 2026 / &lt;/strong&gt;&lt;strong&gt;AIAI Holdings Corporation (NASDAQ:AIAI) (&quot;Ai&lt;sup&gt;2&lt;/sup&gt;&quot; or the &quot;Company&quot;)&lt;/strong&gt;, an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that one of its portfolio companies, Constellation Network, its blockchain and data infrastructure company, will launch its AI security gateway product, Constellation Gate AI, in June 2026. Ahead of the launch, Constellation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/AIAI+Holdings%27+Constellation+Network+Unveils+Gate+AI+Security+Gateway+and+Performance+Benchmarks+Ahead+of+June+Launch/26561657.html</guid>
   <pubDate>Thu, 28 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, May  20, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with advanced AI solutions for clinical trial optimization and precision medicine, today announced its participation in the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida, from May 26 - 29, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;NetraMark’s Founder, Dr. Joseph Geraci, PhD, will contribute to a plenary panel discussion on artificial intelligence in psychiatry. The Company will also present two scientific posters demonstrating the application of its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+to+Present+at+the+American+Society+of+Clinical+Psychopharmacology+Annual+Meeting/26524598.html</guid>
   <pubDate>Wed, 20 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
 </channel>
</rss>
